Drug discovery platform Exscientia sets terms for $275 million US IPO

Robert Marcus
Sep 27, 2021

Related news

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Paige Receives First Ever FDA Approval for AI Product in Digital Pathology

Mar 15
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovation at the intersection of design and technology

Sep 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Exscientia Files For $100M IPO

Nov 3
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Cambridge-1 and the future of medicine

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Biden's top science advisor working on AI Bill of Rights

Jan 10
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts discuss barriers to deep tech ventures

Oct 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Big-name U.S. tech investors are moving in on Europe in increasing numbers

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Europe’s Early-Stage Life Sciences Venture Capitalists Unveil Advocacy Organisation to Drive Innovation and Investment in Health Care

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Mar 2
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X : de l’IA pour réduire le risque lié à l’investissement dans les sciences de la vie